Design, Synthesis, and Structure−Activity Relationship of 6-Alkynylpyrimidines as Potent Adenosine Kinase Inhibitors
Citations Over TimeTop 16% of 2002 papers
Abstract
Adenosine (ADO) is an extracellular signaling molecule within the central and peripheral nervous system. Its concentration is increased at sites of tissue injury and inflammation. One of the mechanisms by which antinociceptive and antiinflammatory effects of ADO can be enhanced consists of inhibition of adenosine kinase (AK), the primary metabolic enzyme for ADO. Novel nonnucleoside AK inhibitors based on 4-amino-6-alkynylpyrimidines were prepared, and the importance of the length of the linker at the 5-position for high affinity AK inhibition was demonstrated. Compounds with 2- and 3-atom linkers were the most potent AK inhibitors. Optimization of their physicochemical properties led to 31a and 37a that effectively reduced pain and inflammation in animal models.
Related Papers
- → Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices(1994)142 cited
- → Aberrant adenosine signaling in patients with focal cortical dysplasia(2023)10 cited
- → Adenosine metabolism in human erythrocytes: A study of some factors which affect the metabolic fate of adenosine in intact red cells in vitro(1980)25 cited
- → Inhibition of adenosine kinase and adenosine uptake in guinea-pig CNS tissue by halogenated tubercidin analogues(1995)11 cited
- → Aberrant adenosine signaling in patients with focal cortical dysplasia(2022)1 cited